Carbamazepine Tablet, Extended Release
Product Images NDC 70518-3699

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 70518-3699). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Carbamazepine 200 mg extended-release oral tablets in a 100 count box. The label shows the brand name with the strength prominently displayed, the dosage form, and quantity per box. The manufacturer is RemedyRepack Inc. with mention that tablets must be swallowed whole and warnings about moisture protection. The NDC number and repackager contact information are also visible.*

FDA Label Image

Mm2 (Carbamazepine 200mg 70518 3699 01)

Carbamazepine 200 mg extended-release oral tablet label showing the quantity of 1 tablet. The label includes the proprietary name with strength, manufacturer details (Cadista Pharma, Inc.), warnings about moisture protection and proper tablet use, storage instructions, and repackager information (RemedyRepack Inc.). A barcode and QR code are also present on the label.*

FDA Label Image

Image Description (Carbamazepine Structure)

Chemical structure diagram of Carbamazepine showing the bicyclic ring system with an amide functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.